Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and Adrenal Cortex Neoplasms

pyrroles has been researched along with Adrenal Cortex Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Arosio, M; Catalano, R; Elli, FM; Giardino, E; Luconi, M; Mangili, F; Mannelli, M; Mantovani, G; Morelli, V; Peverelli, E; Serban, AL; Spada, A; Treppiedi, D1
Benfini, K; degli Uberti, E; Di Pasquale, C; Falletta, S; Feo, C; Gagliano, T; Gentilin, E; Riva, E; Tagliati, F; Zatelli, MC1
Lian, J; Ning, G; Qi, Y; Wang, W; Wang, X; Xu, L; Xu, Y; Zhu, Y1
Bang, SM; Kim, CJ; Kim, H; Kim, JH; Kim, JS; Kim, YJ; Lee, HE; Lee, JO; Lee, JS; Lee, KW1
Cotten, JF; Cuny, GD; Forman, SA; Husain, SS; Kelly, EW; Laha, JK; Liu, A; Miller, KW; Nguyen, HH; Raines, DE; Stewart, D1
Allolio, B; Fassnacht, M; Hahner, S; Johanssen, S; Kroiss, M; Lankheet, N; Laubner, K; Müller, HH; Pöllinger, A; Quinkler, M; Strasburger, CJ; van Erp, NP1
Lin, CI; Moalem, J; Ruan, DT; Whang, EE1

Trials

1 trial(s) available for pyrroles and Adrenal Cortex Neoplasms

ArticleYear
Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial.
    The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:10

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Disease Progression; Drug Interactions; Drug Resistance, Neoplasm; Female; Humans; Indoles; Male; Middle Aged; Mitotane; Pyrroles; Sunitinib; Treatment Outcome; Young Adult

2012

Other Studies

6 other study(ies) available for pyrroles and Adrenal Cortex Neoplasms

ArticleYear
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells.
    Cancer letters, 2021, 01-28, Volume: 497

    Topics: Actin Cytoskeleton; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Filamins; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Insulin-Like Growth Factor II; Mitogens; Pyrazines; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Receptor, Insulin; Signal Transduction; Tumor Cells, Cultured

2021
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors.
    Biochemical pharmacology, 2015, Dec-15, Volume: 98, Issue:4

    Topics: Adrenal Cortex Neoplasms; Antineoplastic Agents; Cell Survival; ErbB Receptors; Growth Inhibitors; Humans; Indoles; Pyrroles; Sunitinib

2015
Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma.
    Oncotarget, 2016, Jun-14, Volume: 7, Issue:24

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Male; Mice, Nude; Middle Aged; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Xenograft Model Antitumor Assays

2016
Metastatic adrenocortical carcinoma treated with sunitinib: a case report.
    Japanese journal of clinical oncology, 2009, Volume: 39, Issue:3

    Topics: Adrenal Cortex Neoplasms; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Resistance, Neoplasm; Humans; Indoles; Male; Mitotane; Pyrroles; Radiotherapy, Adjuvant; Sunitinib; Treatment Failure; Treatment Outcome; Young Adult

2009
Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function.
    Anesthesiology, 2010, Volume: 112, Issue:3

    Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Animals; Drug Design; Electrophysiology; Etomidate; Female; Hemodynamics; Hydrocortisone; Hypnotics and Sedatives; Larva; Male; Postural Balance; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; RNA, Messenger; Structure-Activity Relationship; Xenopus laevis

2010
Strategic combination therapy overcomes tyrosine kinase coactivation in adrenocortical carcinoma.
    Surgery, 2012, Volume: 152, Issue:6

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Combined Chemotherapy Protocols; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Activation; Flavonoids; Humans; Indoles; Phosphorylation; Protein-Tyrosine Kinases; Pyrroles; Receptor Protein-Tyrosine Kinases; Sunitinib

2012